OTC Monograph Reform in the CARES Act: Safety Orders

Поделиться
HTML-код
  • Опубликовано: 27 янв 2021
  • FDA provides an overview of nonprescription drugs, Over-the-Counter (OTC) Monograph Reform, and how FDA identifies and evaluates safety issues. FDA also explains the procedure for FDA-initiated administrative orders to address safety issues and how the public can participate in the administrative order process.
    FDA speakers include Valerie Pratt, MD, and Evelyn Mentari, MD, MS from the
    Office of Nonprescription Drugs in CDER.
    Learn more at: www.fda.gov/drugs/news-events...
    FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.    
    Upcoming Training - www.fda.gov/cdersbia
    SBIA Listserv - public.govdelivery.com/accoun...
    SBIA 2021 Playlist - • 2021 CDER Small Busine...
    SBIA LinkedIn: / cder-small-business-an...
    SBIA Training Resources - www.fda.gov/cdersbialearn
    Twitter - / fda_drug_info
    Email - CDERSBIA@fda.hhs.gov  
    Phone - (301) 796-6707 I (866) 405-5367
  • НаукаНаука

Комментарии •